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Car dio vas cu lar di sea ses and al ler gic di sea ses oc cur com mon ly in de ve lo ped coun tries. They lead to se rious heal th com pli ca tio ns and sig ni fi  can tly 
im pair the qua li ty of li fe. Bo th types of di sea ses are cha rac te ri zed by exces si ve in fl am ma to ry pro ce sses. Re ce nt stu dies sug ge st a li nk be tween al-
ler gy and an in crea sed ri sk of car dio vas cu lar di sea se, re sul ti ng from ove rac ti vi ty of the im mu ne system in al ler gic di sea ses and in crea sed synthe sis 
of proin fl am ma to ry me dia to rs, whi ch has been we ll do cu men ted in the pat ho ge ne sis of at he ros cle ro sis. The aim of this ar tic le is to pre se nt cur re nt 
da ta on the ro le of proin fl am ma to ry fac to rs in the pat ho ge ne sis of car dio vas cu lar di sea ses and al ler gies and on po ten tial re la tion ship be tween the se 
di sor de rs.
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In tro duc tion
Car dio vas cu lar di sea se (CVD) is the lea di ng cau se 
of dea th in de ve lo ped coun tries. Ac cor di ng to the 
Wor ld Heal th Or ga ni za tion (WHO) mo re than 4.5 
mil lion peop le in Eu ro pe die due to car dio vas cu lar 
di sea se, 44% of men and 55% of wo men (1). Equal-
ly im por ta nt heal th and so cial prob lem in the se 
coun tries is the oc cur ren ce of al ler gic di sea ses. It is 
es ti ma ted that al ler gies oc cur in up to 40% of the 
hu man po pu la tion and in mo re than 80 mil lion Eu-
ro pea ns (2,3). Bo th grou ps of di sea ses, due to the 
ve ry hi gh pre va len ce and the pos si bi li ty of se rious 
com pli ca tio ns, con tri bu te to a sig ni fi  ca nt de te rio-
ra tion in pa tien ts’ qua li ty of li fe and their dai ly and 
pro fes sio nal ac ti vi ty.
Pat ho mec ha nis ms of al ler gic di sea ses and car dio-
vas cu lar even ts are com plex and mul ti fac to rial. In 
mo st ca ses car dio vas cu lar di sea se is acqui red, de-
pen de nt on li fe-style and usual ly ma ni fes ti ng af ter 
the age of 40. CVD is main ly cau sed by at he ros cle-
ro sis, lea di ng to im pai red per fu sion, is che mia and 
tis sue nec ro sis. Ma ny ri sk fac to rs pre dis po se to the 
de ve lop me nt of this di sea se, in clu di ng: dysli pi de-
mia, hyper ten sion, dia be tes, smo ki ng and pro-in-
fl am ma to ry ac ti vi ty. De fi  ni te ly le ss freque nt are 
ge ne tic di sor de rs, pre dis po si ng to at he ros cle ro sis, 
su ch as fa mi lial hyper cho les te ro le mia.
On the con tra ry, al ler gy is re la ted to the phe no me-
non of ato py, whi ch is an in na te ten den cy to exces-
si ve IgE synthe sis. Ato pic di sea ses re su lt from the 
hyper sen si ti vi ty of the im mu ne system to an ti ge ns 
in the en vi ron me nt (plan ts, fun gi and ani mal al ler-
ge ns, food and cos me ti cs in gre dien ts), whi ch in 
heal thy peop le do not cau se ad ver se reac tio ns. 
Lo ng-te rm ob ser va tio ns ha ve de ter mi ned that al-
ler gies are defi  ni te ly re la ted to in crea sed le ve ls of 
in fl am ma to ry cyto ki nes. Re ce nt stu dies in di ca te 
the ro le of in ter leu ki n-33, a no vel mem ber of IL-1 
cyto ki ne fa mi ly, and its re cep tor ST2 in dis tin ct di-
sea se pat ho lo gies: pro mo ti ng Th2 cel ls-re la ted in-
fl am ma tion in as thma and al ler gy as we ll as exer ti-
ng at he rop ro tec ti ve eff e ct (4).
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In spi te of diff e ren ces that cou ld al low to exclu de 
the hypot he sis about the re la tion ship be tween 
CVD and al ler gy, it is wor th to em pha si ze that the 
mo st im por ta nt ele me nt whi ch see ms to li nk bo th 
di sor de rs is exces si ve pro-in fl am ma to ry sta te – on 
the one ha nd res pon sib le for the cli ni cal sympto-
ms of al ler gy, on the ot her ha nd as so cia ted wi th 
the pat ho ge ne sis of at he ros cle ro sis.
At he ros cle ro sis is ini tia ted by en dot he lial da ma ge 
due to mec ha ni cal, che mi cal and bio lo gi cal sti mu li 
in clu di ng: hyper ten sion, dysli pi de mia, smo ki ng, 
vi ru ses and bac te ria (for exam ple Chla mydia pneu-
mo niae, He li co bac ter pylo ri) (5). This re sul ts in the 
in fl am ma to ry res pon se - sti mu la tion of en dot he-
lial cel ls, mac rop ha ges and vas cu lar smoo th mus-
cle cel ls to pro du ce ad he sion mo le cu les (VCAM, 
ICAM, se lec tin P and E), whi ch sti mu la te the rec-
ruit me nt of mo no cytes in to su ben dot he lial spa ce 
(6). Li pop ro tei ns mo di fi ed by free ra di ca ls are cap-
tu red in an un con trol led way by sca ven ger re cep-
to rs in mac rop ha ges whi ch are tran sfo rmed to 
foam cel ls and in fi l tra te the in ti ma-me dia layer. Re-
cen tly, it was de mon stra ted that the re nin-an gio-
ten sin system, par ti cu lar ly an gio ten sin II, plays an 
im por ta nt ro le in the pat ho ge ne sis of at he ros cle-
ro sis. An gio ten sin II, par ti ci pa ti ng in the synthe sis 
of ad he sion mo le cu les, in fl am ma to ry cyto ki nes 
and free ra di ca ls is one of the en zymes ac coun ti ng 
for en dot he lial dysfun ction (7).
The ro le of in fl am ma tion in 
at he ros cle ro sis
In fl am ma tion plays an im por ta nt ro le in all sta ges 
of at he ro ge ne sis, from the rec ruit me nt of leu ko-
cytes at the en dot he lium to the at he ros cle ro tic 
plaque rup tu re cau si ng the cli ni cal sympto ms of 
the di sea se (Figure 1).
Inju red en dot he lium sti mu la tes pla te le ts ad he sion 
and re lea se of their me dia to rs: pla te le t-de ri ved 
growth fac tor (PDGF), en dot he lin 1, throm bin, 
tran sfor mi ng growth fac tor β (TGF-β). The se sub-
stan ces are in vol ved in vas cu lar myo cytes hyper-
pla sia and in crea sed pro duc tion of extra cel lu lar 
mat rix, con tai ni ng col la gen type I and III, elas tin, 
pro teog lyca ns (8). In fl am ma to ry-pro li fe ra ti ve chan-
ges in the en dot he lium and the in ti ma lead to pat-
ho lo gic ves sel wa ll re mo de li ng and plaque for ma-
tion.
Plaque da ma ge lea ds to the re lea se of coa gu la tion 
agen ts su ch as col la gen and tis sue fac tor (TF). This 
is fol lowed by ac ti va tion, ad he sion and ag gre ga-
tion of pla te le ts and the ini tia tion of coa gu la tion 
pat hways. In ad di tion, plaque rup tu re re sul ts in ac-
ti va tion of ac cu mu la ted T cel ls and the pro duc tion 
of proin fl am ma to ry cyto ki nes (IL-6, IL-1, TNF-α) and 
pro teo lytic en zymes (metal lop ro tei na ses), in ten si-
fyi ng the in fl am ma to ry res pon se and plaque in sta-
bi li ty (9).
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The sig ni fi  can ce of proin fl am ma to ry 
fac to rs in al ler gy
In crea sed in fl am ma to ry pro ces ses are cha rac te ris-
tic for all al ler gic di sea ses. This phe no me non is re-
la ted to the pat ho lo gi cal, exces si ve reac ti vi ty of ef-
fec tor cel ls in vol ved in im mu ne res pon se: T lympho-
cytes, ma st cel ls, ba sop hi ls and sec re ted me dia to rs 
and cyto ki nes. The se sub stan ces are res pon sib le 
for the ma ni fes ta tion of cli ni cal sympto ms.
Al ler gic reac tio ns pro ceed ac cor di ng to the IgE-
de pen de nt mec ha ni sm of hyper sen si ti vi ty (type I) 
(10). In te rac tion be tween the al ler gen (alien an ti-
gen) and IgE an ti bo dies re si di ng on the sur fa ce of 
ma st cel ls and ba sop hi ls cau ses deg ra nu la tion and 
relea se of me dia to rs: pre for med - his ta mi ne, 
trypta se, chyma se, car boxypep ti da se A (CPA) and 
synthe si zed de no vo - leu kot rie nes, pros tag lan di ns 
D2 (PGD2), pla te le t-ac ti va ti ng fac tor (PAF) (Figure 
2). Th2 lympho cytes re gu la te the ac ti vi ty of ma st 
cel ls, ba sop hi ls and eo si nop hi ls and pro du ce cyto-
ki nes and growth fac to rs (in clu di ng IL-6, TGF-β). 
Cli ni cal sympto ms are main ly re la ted wi th bio ge-
nic ami nes (es pe cial ly his ta mi ne) that in crea se the 
per mea bi li ty of blood ves se ls and cau se ede ma. 
His ta mi ne cau ses con trac tion of smoo th mus cles 
of in ter nal or ga ns (li ke bron chi) (11). Eff ec ts of IgE-
me dia ted reac tion may be eit her lo cal or syste mic 
anap hylaxis, whi ch is a li fe-threa te ni ng con di tion. 
Sec re ted proin fl am ma to ry cyto ki nes sti mu la te the 
in fl ux of eff ec tor cel ls and in crea se bo th lo cal and 
syste mic sympto ms. It shou ld be no ted that al ler gy 
sympto ms ap pear on ly af ter mul tip le expo su re to 
the al ler gen, whi le du ri ng the fi r st con ta ct spe ci fi c 
IgE di rec ted again st spe ci fi c an ti ge ns are pro du ced.
FIGURE 2. Mec ha ni sm of IgE-de pen de nt reac tion and ac ti va tion of in fl am ma to ry fac to rs in al ler gy.
In fl am ma tion – a com mon de no mi na tor 
for al ler gies and in crea sed 
car dio vas cu lar ri sk?
The eff e ct of proin fl am ma to ry fac to rs in the pat-
ho ge ne sis of CVD and al ler gies has been we ll des-
cri bed and do cu men ted in nu me rous po pu la tion 
stu dies. Al thou gh avai lab le li te ra tu re pay li mi ted 
at ten tion on re la tion ship be tween the se di sea ses 
it is wor th con si de ri ng the po ten tial im pa ct of fac-
to rs in vol ved in the hyper sen si ti vi ty mec ha nis ms 
to the car dio vas cu lar system fun ctio ns.
The ta sk of the im mu ne system is a de fen se again-
st fo rei gn an ti ge ns, re cog ni zed as fac to rs po ten-
tial ly pat ho ge nic and har mful - mic roor ga nis ms, 
toxi ns, al te red or da ma ged cel ls. Howe ver, it does 
not always bri ng be ne fi  cial eff ec ts for heal th, and 
even a slig ht de via tion can dis ru pt the pro per fun-
ctio ni ng of the system. It see ms that in the ca se of 
IgE + allergen
basophils and mast cells
activation
– biogenic amines: histamine, serotonin
– enzymes: chymase, tryptase, CPA
PREFORMED MEDIATORS:
– leukotriens, PGD2, PAF
– cytokines: TNF-alpha, IL-1, IL-6
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Fac to rs as so cia ted wi th al ler gic di sea ses The po ten tial ro le in the pat ho ge ne sis of CVD
in crea sed le ve ls of IgE, ma st cel ls and ba sop hi ls sti mu- -
la tion, sec re tion of his ta mi ne and proin fl am ma to ry 
cyto ki nes
in crea sed le ve ls of acu te pha se pro tei ns (CRP, SAA) -
en dot he lium da ma ge, leu ko cytes rec ruit me nt, free  -
ra di ca ls in duc tion and oxi da tion of li pop ro tei ns
synthe sis of me tal lop ro tei na ses, plaques dis rup tion  -
and clot for ma tion
cor ti cos te roi ds and β2-ago nis ts treat me nt - com pli ca tio ns re la ted to exten ded use: dysli pi de mia,  -
dia be tes, hyper ten sion, ab do mi nal obe si ty (me ta bo-
lic syndro me com po nen ts)
tac hycar dia, is che mia and hea rt fai lu re -
low vi ta min D con cen tra tion - in crea sed ri sk of in su lin re sis tan ce, dia be tes, hyper- -
ten sion, obe si ty, hyper trig lyce ri de mia - stro ng CVD 
ri sk fac to rs 
TABLE 1. The po ten tial im pa ct of al ler gic di sea ses at in crea sed car dio vas cu lar ri sk.
ato pic di sea ses, es pe cial ly chro nic and of ten oc-
cur ri ng exa cer ba tio ns, exces si ve ac ti vi ty of sti mu-
la ted eff ec tor cel ls and in du ced bioc he mi cal reac-
tio ns may be im por ta nt, al thou gh cer tain ly are not 
the on ly, po ten tial fac to rs of in crea sed car dio vas-
cu lar ri sk (Table 1).
Ba sop hi ls, ma st cel ls and me dia to rs of
IgE-de pen de nt reac tion
The con tri bu tion of ba sop hi ls, ma st cel ls and proin-
fl am ma to ry cyto ki nes, in clu di ng IL-1, IL-6, IL-8, 
TNF-α and newly dis co ve red IL-33 in hyper sen si ti-
vi ty reac tio ns play a key ro le in ato pic di sea ses su-
ch as bron chial as thma and al ler gic rhi ni tis (12,13). 
Sig ni fi  can tly in crea sed le ve ls of in ter leu ki n-6 and 
TNF-α can be ob ser ved par ti cu lar ly du ri ng exa cer-
ba tio ns, and their con cen tra tion cor re la tes wi th 
the prog res sion of di sea ses. In re ce nt yea rs mu ch 
at ten tion has been paid to the par ti ci pa tion of the-
se fac to rs not on ly in im mu ne-re la ted di sea ses, 
but al so in the pro ce ss of at he ro ge ne sis. Nu me-
rous stu dies in di ca ted exces si ve ac cu mu la tion of 
ma st cel ls in the da ma ged en dot he lium whi ch on 
the one ha nd sti mu la te the for ma tion of foam cel ls 
and at he ros cle ro tic plaques, and on the ot her ha-
nd is an im por ta nt ele me nt res pon sib le for the 
deg ra da tion of plaques and ini tia tion of coa gu la-
tion due to cyto ki nes re lea sed from the gra nu les 
and pro teo lytic en zymes (14,15). In crea sed le ve ls 
of bo th IL-6 and TNF-α, ac cor di ng to ear lier re por-
ts, may be used as no n-tra di tio nal and no n-li pid 
CVD ri sk fac to rs. The STANISLAS stu dy eva lua ted a 
po ten tial re la tion ship be tween proin fl am ma to ry 
cyto ki nes con cen tra tio ns and tra di tio nal and new 
at he ros cle ro sis ri sk fac to rs in a po pu la tion of you-
ng heal thy in di vi dua ls (16). Stro ng po si ti ve cor re la-
tion was ob ser ved be tween the con cen tra tio ns of 
IL-6 and TNF-α and CRP, as we ll as the re la tion ship 
be tween IL-6 and ad he sion mo le cu les (ICA M-1, 
L-se lec tin). Im por tan tly, IL-6 al so showed a stro ng 
ne ga ti ve cor re la tion wi th se rum con cen tra tio ns of 
apo li pop ro tein A-I and HDL cho les te rol whi ch are 
in vol ved in the re ver se cho les te rol tran spo rt from 
the blood to the li ver and ha ve a stro ng an ti-at he-
ro ge nic eff e ct. In te res tin gly, re ce nt re por ts sug ge-
st in crea sed expres sion of mo no cyte che mo tac tic 
pro tein (MCP-1) bo th in al ler gies and CVD, whi ch 
in du ces mo no cytes and mac rop ha ges che mo taxis 
to the da ma ged en dot he lium du ri ng at he ro ge ne-
sis and al so sti mu la tes the synthe sis of IL -1, IL-6 
and ba sop hi ls deg ra nu la tion in ato pic reac tio ns 
(17). Abo ve men tio ned IL-33 is in vol ved in in crea-
sed sec re tion of IL-5, IL-10 and IL-13 by Th2 cel ls 
whi ch re sul ts in mac rop ha ges, den dri tic cel ls, ma st 
cel ls, ba sop hi ls and epit he lial cel ls ac ti va tion and 
is res pon sib le for bron chial spa sm and mu cus pro-
duc tion in as thma pa tien ts (4). Thou gh its stro ng 
pro-in fl am ma to ry ac ti vi ty, se ve ral stu dies ha ve 
shown that IL-33 has al so an ti-in fl am ma to ry pro-
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per ties, whi ch can po ten tial ly dec rea se a car dio-
vas cu lar ri sk. IL-33 re du ces le ve ls of I FN-γ and Th1-
ce ll cou nt in lymph no des due to the sug ges ted 
swit ch from Th1 to at he ro-pro tec ti ve Th2 im mu ne 
res pon se (18). Mo reo ver, it is a po te nt an ti-at he ro-
ge nic fac tor, whi ch in hi bi ts the for ma tion of foa m-
cel ls by re du ci ng ace tyla ted and oxi di zed low-den-
si ty li pop ro tein up ta ke, indu ces pro duc tion of nit-
ric oxi de and plays be ne fi  cial ro le in ho meos tat sis 
of adi po se tis sue and glu co se (4,19). Howe ver, it 
shou ld be con si de red whet her the pro tec ti ve ef-
fec ts of IL-33 are suffi   cie nt to off set the pro-in fl am-
ma to ry pro per ties of ot her cyto ki nes.
In crea sed le ve ls of bio ge nic ami nes, es pe cial ly his-
ta mi ne re lea sed du ri ng al ler gic reac tion, res pon-
sib le for the for ma tion of ede ma, may al so be a 
pre dis po si ng fac tor for at he ros cle ro sis. Ele va ted 
num ber of ma st cel ls, re sul ti ng in an in crea sed 
con cen tra tion of his ta mi ne is ob ser ved in at he ros-
cle ro sis out brea ks. His ta mi ne cau ses loo se ni ng of 
the con nec tio ns be tween the en dot he lial cel ls, in-
crea ses their per mea bi li ty and thus fa ci li ta tes the 
in fl ow of proat he ro ge nic li pop ro tei ns and ot her 
sub stan ces for mi ng at he ros cle ro tic plaques (20). 
Growth fac to rs and cyto ki nes, re lea sed si mul ta-
neous ly from the ac ti va te ded ma st cel ls cau se in-
crea sed synthe sis of free ra di ca ls and chan ges in 
the vas cu lar myo cytes, whi ch pro vo kes the en dot-
he lium inju ry, pro li fe ra tion and in fl am ma to ry pro-
ces ses. His ta mi ne, throu gh its in fl uen ce on vas cu-
lar mus cle reac ti vi ty, may be as so cia ted wi th per-
fu sion di sor de rs and car diac ar r hythmia.
Re ce nt stu dies em pha si ze im por ta nt ro le of syste-
mic anap hylaxis in pat ho lo gies of the car dio vas cu-
lar system. The cli ni cal pic tu re of anap hylaxis is do-
mi na ted by sympto ms of car diac and pe rip he ral 
cir cu la tion, es pe cial ly hypo ten sion, he mo dyna mic 
sho ck, car diac ar r hythmia and myo car dial in far-
ction, whi ch are the mo st com mon di re ct cau se of 
dea th. This con di tion is as so cia ted wi th the pre-
sen ce of car diac ma st cel ls, whi ch diff er from pe-
rip he ral ma st cel ls in their abi li ty to be ac ti va ted 
by sti mu li ot her than IgE, in clu di ng C3a and C5a 
anap hylo toxi ns, sub stan ce P and eo si nop hil ca tio-
nic pro tein (ECP) (21). Ele va ted ECP known as a clas-
sic expo ne nt of ato pic di sea ses (li ke as thma) and 
al ler gic in fl am ma tion in re ce nt yea rs has be co me 
the ob je ct of in te re st to car dio lo gis ts be cau se of 
the in fl uen ce of ECP ac ti vi ty on at he ro ge ne sis. Pro-
bab ly ECP may be in vol ved in mo no cytes ad he-
sion on en dot he lial cel ls and in coa gu la tion cas ca-
de (22). Moreo ver, car diac ma st cel ls are cha rac te ri-
zed by the sec re tion of unu sual ly lar ge amoun ts of 
me dia to rs, par ti cu lar ly chyma se, leu kot rie nes, 
PGD2 and PAF, whi ch may in du ce ar r hythmias, dec-
rea sed co ro na ry fl ow, myo car dial in far ction and 
sud den car diac dea th. It is no tewor thy that chyma-
se has the po ten tial ac ti vi ty of the an gio ten sin 
con ver ti ng en zyme (ACE) and is ab le to con ve rt 
an gio ten sin I to an gio ten sin II (A ng II). Al thou gh 
Ang II and its re cep tor AT2 ha ve do cu men ted as so-
cia tion wi th the de ve lop me nt of car dio vas cu lar di-
sea se as fac to rs cau si ng hyper ten sion and pro mo-
ti ng ce ll growth and apop to sis, pro-oxi da nt and 
pro-in fl am ma to ry pro ces ses (23,24), the ro le of 
ACE is not clear ly explai ned yet. The re view pub lis-
hed by Nawaz et al. sum ma ri zes pre vious fi n din gs 
about the im por tan ce of ACE and its po lymor phi-
sm as a CHD ri sk fac tor (25). In crea sed ACE ac ti vi ty 
is ob ser ved in ho mo zygous de le tion D/D ge no-
type, in the opi nion of ma ny re sear che rs, is stron-
gly as so cia ted wi th the de ve lop me nt of hyper ten-
sion and at he ros cle ro sis. Howe ver, the re sul ts from 
re ce nt stu dies do not con fi  rm un doub ted ly the re-
la tion ship be tween po lymor phi sm-re la ted ACE ac-
ti vi ty and in crea sed car dio vas cu lar ri sk and cer-
tain ly requi re mo re de tai led ana lysis. Pla te le ts-ac-
ti va ti ng fac tor plays a dual ro le in the pat ho ge ne-
sis of CVD - on the one ha nd pro mo tes leu ko cytes 
and mac rop ha ges che mo taxis and the sec re tion 
of lytic en zymes that da ma ge the at he ros cle ro tic 
plaques, on the ot her ha nd sti mu la tes the ag gre-
ga tion of pla te le ts at the si te of inju ry and clot for-
ma tion.
Im mu nog lo bu lin E and acu te pha se 
pro tei ns
Se rum to tal IgE (tI gE), des pi te the qui te sma ll spe-
ci fi  ci ty for al ler gic di sea ses, is one of the ba sic la-
bo ra to ry tes ts used in their diag no sis. It is be lie ved 
that in crea sed le ve ls of tI gE to 500 IU/mL is sympto-
ma tic of al ler gies. Ja far za deh et al. ob ser ved the 
re la tion ship be tween IgE and the oc cur ren ce of 
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acu te co ro na ry syndro mes (ACS). In a stu dy of 90 
sub jec ts: 30 wi th acu te myo car dial in far ction, 30 
wi th un stab le an gi na and 30 heal thy sub jec ts (con-
trol group), hig her mean IgE le ve ls we re fou nd in 
ACS pa tien ts than in con tro ls (26). In pa tien ts wi th 
myo car dial in far ction le ve ls of IgE we re sig ni fi  can-
tly hig her com pa red to the con trol group (367.1 vs. 
136 UI/mL, P < 0.01). Amo ng men, the re sul ts al so 
diff e red sig ni fi  can tly, bei ng the hig he st in men wi-
th myo car dial in far ction, lower in un stab le an gi na 
and the lowe st in con trol group (P < 0.05). The aut-
ho rs explain this phe no me non by in te rac tion of 
IgE wi th ma st cel ls and ba sop hi les. Va soac ti ve sub-
stan ces and cyto ki nes re lea sed from the gra nu les 
of the se cel ls may be an im por ta nt fac tor for co ro-
na ry hea rt di sea se. Si mi lar re sul ts we re re cen tly 
ob ser ved by ot he rs in pa tien ts suff e ri ng from dif-
fe re nt for ms of is che mic hea rt di sea se (27). Males 
wi th acu te myo car dial in far ction tur ned out to ha-
ve sig ni fi  can tly hig her tI gE con cen tra tio ns than fe-
ma les and con tro ls.
C-reac ti ve pro tein, as sayed by a hi gh sen si ti vi ty 
met hod (hsCRP), is a stan da rd pa ra me ter to the as-
ses sme nt of mi ld in fl am ma tion. Ele va ted hsCRP 
con cen tra tio ns wit hin 1-3 mg/L and abo ve 3 mg/L 
are con si de red as mo de ra te and hi gh ra te of re la ti-
ve ri sk of CVD. Lin ob ser ved hi gh con cen tra tio ns of 
CRP (mean 13.9 mg/L) in pa tien ts wi th re cur re nt 
ur ti ca ria and an gioe de ma (28). The re la tion ship 
be tween CRP and the se ve ri ty of cli ni cal sympto-
ms was al so fou nd. Sa hoo et al. do cu men ted hig-
her con cen tra tio ns of CRP in pa tien ts with ato pic 
as thma than in heal thy sub jec ts, but the ave ra ge 
va lue was sig ni fi  can tly lower than for no n-al ler gic 
pa tien ts wi th as thma (2.9 vs. 8.3 mg/L, P < 0.001) 
(29). This may in di ca te the par ti ci pa tion of CRP in 
in fl am ma to ry reac tio ns and sug ge sts a pos sib le la-
ck of as so cia tion of CRP wi th al ler gic as thma. Some 
aut ho rs al so sug ge st a re la tion ship be tween the 
pre va len ce of al ler gic res pi ra to ry di sea se and an 
in crea sed con cen tra tion of se rum amyloid A (SAA) 
(30). Ac cor di ng to The Car dio vas cu lar Ri sk in You-
ng Fin ns Stu dy, hig her le ve ls of SAA are re la ted to 
at he ros cle ro sis and me ta bo lic syndro me ri sk fac-
to rs, in clu di ng low con cen tra tion of apo li pop ro-
tein A-I, HDL-cho les te rol, lep tin and hig her va lues 
of BMI, CRP and in ti ma-me dia thic kne ss (31).
Phar ma cot he ra py in ato pic di sea ses
Phar ma co lo gi cal the ra py may be an im por ta nt 
fac tor of in crea sed car dio vas cu lar even ts in al ler-
gic pa tien ts. The fa ct is that prac ti cal ly all kin ds of 
al ler gic di sea ses are trea ted by glu co cor ti coi ds be-
cau se of their po te nt an ti-in fl am ma to ry and im-
mu no sup pres si ve eff ec ts (32). The use of glu co cor-
ti coi ds can re du ce the frequen cy of cli ni cal re lap-
ses to a mi ni mum and great ly im pro ve the qua li ty 
of li fe. Howe ver, dis con ti nua tion of treat me nt ge-
ne ral ly re sul ts in re cur ren ce and exa cer ba tion of 
al ler gy sympto ms; hen ce the re is a need for their 
chro nic usa ge. Glu co cor ti coi ds, as sub stan ces 
synthe si zed by the ad re nal glan ds, are in vol ved in 
the re gu la tion of car bo hydra te, pro tein, li pid and 
wa te r-e lec tro lyte me ta bo li sm. Howe ver, pro lon-
ged use of exo ge nous glu co cor ti coi ds con tri bu tes 
to se rious dis tur ban ces in ho meos ta sis, re sul ti ng 
in the de ve lop me nt of sympto ms su ch as hyper-
glyce mia, dysli pi de mia, ab do mi nal obe si ty and 
hyper ten sion, es pe cial ly in syste mic treat me nt 
(32). Se ve ral stu dies sug ge st al so a pos si bi li ty of 
syste mic ab sor ption of to pi cal ste roi ds and in ci-
den ce of si mi lar si de eff ec ts (33,34). The se di sor de-
rs are com po nen ts of me ta bo lic syndro me and 
stro ng CVD ri sk fac to rs (35).
A com mon ly used al go rit hm in pa tien ts wi th bron-
chial as thma is a com bi na tion of glu co cor ti coid 
and β-adrenergic re cep to rs ago nis ts that en han ce 
the an ti-in fl am ma to ry ac ti vi ty and ope ra te a re-
laxa nt eff e ct on bron chial smoo th mus cles, eli mi-
na ti ng at tac ks of breat hles sne ss. Da ta from re ce nt 
yea rs stres sed that the pro lon ged use of β-a go nis-
ts in pa tien ts wi th as thma and chro nic ob struc ti ve 
pul mo na ry di sea se (COPD) may in crea se the ri sk of 
car dio vas cu lar di sea se. In a me ta-a na lysis of 33 
stu dies whi ch in clu ded 13 sin gle-do se and 20 of 
lon ger du ra tion (from 3 days to 1 year) tria ls Sal pe-
ter et al. ob ser ved 2.5 ti mes hig her ri sk of acu te co-
ro na ry syndro me amo ng sub jec ts wi th as thma 
and COPD trea ted wi th in ha led/nebulized β2-
agonists than in the con tro ls (36). The aut ho rs sug-
ge st that con ti nuous sti mu la tion of β-ad re ner gic 
re cep to rs may lead to is che mia, ar r hythmia and 
hea rt fai lu re due to an in crea se ra te of myo car dial 
con trac tion and re du ced po tas sium con cen tra-
tion.
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Re ce nt re por ts re gar di ng the treat me nt of al ler gic 
di sea ses in di ca te the im por ta nt ro le of vi ta min D3 
sup ple men ta tion, es pe cial ly in chil dren and ado-
les cen ts. Sea ri ng et al. stu died se rum vi ta min 
25(OH)D sta tus in 100 chil dren wi th bron chial as-
thma trea ted wi th cor ti cos te roi ds (37). Hypo vi ta-
mi no sis (< 30 ng/mL) and mo de ra te de fi  cien cy (< 
20 ng/mL) was ob ser ved in 47% and 17% of pa-
tien ts, res pec ti ve ly. A weak but sta tis ti cal ly sig ni fi -
ca nt ne ga ti ve cor re la tion be tween 25(OH)D and 
IgE (r = -0.25; P = 0.01) and the num ber of po si ti ve 
re sul ts of al ler gy skin tes ts (r = -0.23; P = 0.02) was 
no ted. Fur ther mo re, a weak sig ni fi  ca nt po si ti ve 
cor re la tion be tween se rum 25(OH)D and the ca pa-
ci ty of the lun gs was ob ser ved. The aut ho rs sug-
ge st that low con cen tra tion of vi ta min 25(OH)D 
may in crea se the se ve ri ty of cli ni cal sympto ms of 
as thma, whe reas nor mal con cen tra tion sti mu la tes 
the ac tion of glu co cor ti coi ds. The aut ho rs ha ve al-
so con clu ded that vi ta min D sup ple men ta tion 
cou ld lead to re duc tion in drug do se and cou ld im-
pro ve the heal th of pa tien ts. Con su mi ng adequa te 
amoun ts of vi ta min D and its op ti mal con cen tra-
tion in the blood (> 30 ng/mL) in chil dren and ado-
les cen ts may re du ce the ri sk of au toim mu ne di sea-
ses, as thma, res pi ra to ry in fec tio ns, as we ll as 
hyper ten sion and car dio vas cu lar di sea se. The op ti-
mal thres ho ld for se rum vi ta min 25(OH)D for no n-
ske le tal heal th be ne fi  ts is cur ren tly the sub je ct of 
in te re st of ma ny stu dies. The bio lo gi cal ly ac ti ve fo-
rm of vi ta min D – 1,25(OH)2D is a po te nt, pleiot ro-
pic hor mo ne aff ec ti ng nu me rous or ga ns and tis-
sues throu gh bin di ng to its cel lu lar re cep to rs. Vi ta-
min D ac ti va tes mo re than 200 ge nes and mo du la-
tes ge ne expres sion whi ch may sug ge st its pos sib-
le ro le in ma ny ot her heal th di sor de rs li ke dia be tes, 
can cer, mul tip le scle ro sis, hyper ten sion, Al zhei-
mer’s di sea se etc. (38). Howe ver, this nee ds to be 
con fi r med in lar ge pros pec ti ve stu dies and we ll-
de sig ned cli ni cal tria ls.
NHANES III stu dies showed a 2-fold hig her in ci den-
ce of hyper ten sion in pa tien ts wi th vi ta min D de fi -
cien cy. Lower con cen tra tion of vi ta min 25(OH)D 
was al so as so cia ted wi th hig her ri sk of dia be tes, 
obe si ty, hyper trig lyce ri de mia and a hig her per cen-
ta ge of mor ta li ty from car dio vas cu lar di sea se (39).
Al ler gies and CVD ri sk in re ce nt stu dies
At pre se nt, the da ta con cer ni ng the as ses sme nt of 
CVD ri sk in al ler gic di sea ses is qui te scar ce. Des cri-
bed in a few il lus tra ti ve wor ks (40,41) the re la tion-
ship be tween an in crea sed co ro na ry ri sk and chro-
nic in fl am ma tion du ri ng al ler gies ha ve not been 
so far con fi r med by unequi vo cal re sul ts of cli ni cal 
tria ls. The re ce nt stu dy of Kim et al. sug ges ts an as-
so cia tion be tween the ri sk of co ro na ry hea rt di sea-
se (CHD) wi th com mon ly oc cur ri ng sympto ms of 
al ler gies su ch as rhi no co njun cti vi tis (RC) and whee-
zi ng (WH) (42). In the group of 8,653 sub jec ts over 
the age of 20, ta ki ng pa rt in the NHANES III in 1988-
1994 the frequen cy of al ler gic sympto ms was ana-
lyzed. CHD was ob ser ved in 5.9% of the sur veyed 
po pu la tion, near ly in 13% of pa tien ts wi th WH, 5% 
wi th RC and 4% of heal thy in di vi dua ls. Pa tien ts wi-
th WH we re cha rac te ri zed by a sig ni fi  can tly hig her 
pre va len ce of hyper ten sion and ab do mi nal obe si-
ty and sig ni fi  can tly hig her ave ra ge CRP con cen tra-
tion than the ot her two grou ps (4.7 vs. 3.7 and 3.9 
mg/L, res pec ti ve ly; P = 0.008). Re sul ts of mul ti va-
ria te reg res sion ana lysis showed a sig ni fi  ca nt cor-
re la tion be tween the WH and the ri sk of CHD, com-
pa red wi th heal thy sub jec ts. Af ter ad jus ti ng for ot-
her ri sk fac to rs for CVD, in clu di ng hi gh blood pres-
su re, to tal cho les te rol, HDL-C and CRP le ve ls and 
the in ci den ce of type 2 dia be tes, a 2.6-fold hig her 
ri sk of CHD in pa tien ts wi th WH and 40% hig her ri-
sk in the group wi th RC was no ted as com pa red 
wi th con tro ls. The aut ho rs explain des cri bed re la-
tion ship by chro nic in fl am ma to ry res pon se, re sul-
ti ng from exces si ve synthe sis of proin fl am ma to ry 
cyto ki nes in ato pic reac tio ns. The mo st sig ni fi  ca nt 
diff e ren ces in te st re sul ts we re ob ser ved amo ng 
wo men be low 50 yea rs of age - pro bab ly this con-
di tion as so cia ted wi th a hig her con cen tra tion of 
es tro gen in pre me no pau sal wo men, whi ch in crea-
se the sen si ti vi ty of the im mu ne system and ac ti-
va te ma st cel ls and ba sop hi ls. Howe ver in te res ti ng 
re sul ts of this stu dy do not show clear ly a re la tion-
ship be tween al ler gy and CVD. Mo reo ver, the pre-
sen ce of al ler gy and co ro na ry hea rt di sea se wa sn’t 
as ses sed by diag nos tic tes ts, but by ques tion nai-
res, whi ch ha ve re la ti ve ly low sen si ti vi ty and spe ci-
fi  ci ty for diag no sis. The aut ho rs al so in di ca te that 
dru gs used by pa tien ts, es pe cial ly β-a go nis ts a 
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may ha ve had a sig ni fi  ca nt im pa ct on the re sul ts of 
the ana lysis.
Con clu sio ns
The hypot he sis of the re la tion ship be tween al ler-
gies and CVD ri sk is a mat ter of con tro ver sy. It is 
pos sib le that chro nic al ler gic di sea ses, and thus lo-
ng-las ti ng in crea sed in fl am ma tion, refl ec ted by in-
crea sed le ve ls of proin fl am ma to ry cyto ki nes may 
con tri bu te to pat ho lo gi cal chan ges in the cir cu la-
to ry system. This prob lem requi res fur ther po pu la-
tion stu dies. Ho pe ful ly, in the fu tu re they wi ll pro-
vi de va luab le in sig hts in to the pat ho ge ne sis of at-
he ros cle ro sis and the pre ven tion of car dio vas cu lar 
di sea se.
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Pos to ji li po ve za no st iz me đu aler gi je i kar dio vas ku lar nih bo les ti?
Sažetak
Kar dio vas ku lar ne bo les ti i aler gij ske bo les ti uo bi ča je ne su u raz vi je nim zem lja ma. One do vo de do oz bilj nih zdrav stve nih kom pli ka ci ja i zna čaj no 
na ru ša va ju kva li te tu ži vo ta. Oba ti pa bo les ti ka rak te ri zi ra prein ten zi van upal ni pro ces. No vi ja is tra ži va nja pret pos tav lja ju da pos to ji ve za iz me đu 
aler gi je i po ve ća nog ri zi ka od kar dio vas ku lar nih bo les ti zbog pret je ra ne ak tiv nos ti imu no loš kog sus ta va kod aler gij skih bo les ti i po ja ča ne sin te ze 
prou pal nih me di ja to ra što se dob ro vi di iz pa to ge ne ze ate ros kle ro ze. U ovom član ku že li mo iz ni je ti tre nut ne spoz na je o ulo zi prou pal nih čim be ni-
ka u pa to ge ne zi kar dio vas ku lar nih bo les ti i aler gi je te po dat ke o po ten ci jal noj ve zi iz me đu tih po re me ća ja.
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